National Key Monitoring Drug Rational Use Management Standards

XU Feifei; BIAN Yuan; HAN Yong; YAN Junfeng; TONG Rongsheng

doi:null

您当前的位置：

首页 >

文章列表页 >

National Key Monitoring Drug Rational Use Management Standards

更新时间：2025-09-25

- National Key Monitoring Drug Rational Use Management Standards
- ZHONGGUO YAOFANG Pages: 1-6(2025)
- 作者机构：
  
  1.四川省医学科学院·四川省人民医院，药学部
  2.电子科技大学医学院，个体化药物治疗四川省重点实验室
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published Online：22 August 2023，
- 稿件说明：
移动端阅览
徐菲飞,边原,韩勇,等.国家重点监控药品合理用药管理规范[J].中国药房,

XU Feifei,BIAN Yuan,HAN Yong,et al.National Key Monitoring Drug Rational Use Management Standards[J].ZHONGGUO YAOFANG,
徐菲飞,边原,韩勇,等.国家重点监控药品合理用药管理规范[J].中国药房, DOI：10.6039/j.issn.1001-0408...01.

XU Feifei,BIAN Yuan,HAN Yong,et al.National Key Monitoring Drug Rational Use Management Standards[J].ZHONGGUO YAOFANG, DOI：10.6039/j.issn.1001-0408...01.

摘要

目前，国家重点监控药品的合理使用管理缺乏统一的规范。根据国家的相关要求，为使国家重点监控药品在各级医疗机构的更加合理使用和规范管理，由中华医学会临床药学分会、中国药学会药物流行病学专委会及四川省药学会药物流行病学专委会组织专家充分讨论，根据近年来国内外发布的相关文献并结合全国多家医疗机构对国家重点监控药品的管理实践，形成本管理规范。本规范主要从重点监控药品的合理使用基本原则及重点监控药品监管办法提出相关意见和建议，特别是对怎样加强重点监控药品的药事管理和使用管理提出参考建议。

Abstract

At present

there is a lack of unified and standardized management for the rational use of national key monitoring drugs. According to the relevant requirements of the state

in order to make the national key monitored drugs more reasonable use and standardized management in medical institutions at all levels

the Clinical pharmacy Branch of the Chinese Medical Association

the Pharmaceutical Epidemiology Special Committee of the Chinese Pharmaceutical Association and the Pharmaceutical Epidemiology Special Committee of the Sichuan Pharmaceutical Association organized experts to fully discuss

based on the relevant literature published at home and abroad in recent years and combined with the management practice of many medical institutions across the country on the national key monitored drugs

Form this management standard. This standard mainly provides relevant opinions and suggestions on the basic principles of rational use of key monitored drugs and the regulatory measures for key monitored drugs

especially on how to strengthen the pharmaceutical management and use management of key monitored drugs.

关键词

Keywords

references

国家卫生健康委员会医政医管局 . 《关于印发国家重点监控合理用药药品目录调整工作规程的通知》解读 . [ 2021-09-03 ] http://www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml

王笛，王相峰，毛丽超，等 . 我国医疗机构重点监控药品监测平台合理应用管理指标的探讨 [J ] . 中国药房， 2021 ， 32 （ 08 ）： 911 - 914 .

黎赛，盛小燕，梁椅文，等 . 我院重点监控药品管理实践和干预措施探讨 [J ] . 中国药房， 2018 ， 29 （ 22 ）： 3029 - 3034 .

国家卫生健康委员会医政医管局 . 关于进一步加强用药安全管理提升合理用药水平的通知 . [ 2022-07-27 ] http://www.nhc.gov.cn/yzygj/s7659/202207/007020b813ce446ba3cab3258775270a.shtml http://www.nhc.gov.cn/yzygj/s7659/202207/007020b813ce446ba3cab3258775270a.shtml

国家卫生健康委员会医政医管局 . 国家卫生健康委办公厅关于印发国家重点监控合理用药药品目录调整工作规程的通知 . [ 2021-09-03 ] http://www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752fb1b12d21b98.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752fb1b12d21b98.shtml

国家卫生健康委员会 . 国家卫生健康委办公厅关于印发第二批国家重点监控合理用药药品目录的通知 .[ 2023-01-13 ] http://www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae64b4e56a10f9ea910e11426.shtml http://www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae64b4e56a10f9ea910e11426.shtml .

国家卫生健康委 . 国家卫生健康委办公厅关于印发新型抗肿瘤药物临床应用指导原则（2021年版）的通知 .[ 2021-12-27 ] http://www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml http://www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Rational use management standards of national key monitoring drug

Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine

Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined with thyroid cancer

Related Author

XU Feifei

BIAN Yuan

HAN Yong

YAN Junfeng

TONG Rongsheng

YANG Yumin

LI Xiumin

WANG Lu

Related Institution

Dept. of Pharmacy， Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital

Personalized Drug Therapy Key Laboratory of Sichuan Province， School of Medicine， University of Electronic Science and Technology of China

Dept.of Pharmacy， Baoding No.1 Central Hospital

Dept. of Pharmacy， Medical Supplies Center， Chinese PLA General Hospital

Dept. of Oncology， Qilu Hospital of Shandong University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰